Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-κB pathways

✍ Scribed by Chen-Ming Su; Dah-Yuu Lu; Chin-Jung Hsu; Hsien-Te Chen; Chun-Yin Huang; Wei-Hung Yang; Yi-Chang Su; Shu-Ning Yang; Yi-Chin Fong; Wen-Pei Tseng; Chih-Hsin Tang

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 329 KB
• Volume: 220
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.21802

✦ Synopsis

Abstract

Invasion of tumor cells is the primary cause of therapeutic failure in the treatment of malignant chondrosarcomas. Glial cell‐derived neurotrophic factor (GDNF) plays a crucial role in migration and metastasis of human cancer cells. Integrins are the major adhesive molecules in mammalian cells. Here we found that GDNF directed the migration and increased cell surface expression of αv and β3 integrin in human chondrosarcoma cells. Pretreated of JJ012 cells with MAPK kinase (MEK) inhibitors PD98059 or U0126 inhibited the GDNF‐mediated migration and integrin expression. Stimulation of cells with GDNF increased the phosphorylation of MEK and extracellular signal‐regulating kinase (ERK). In addition, NF‐κB inhibitor (PDTC) or IκB protease inhibitor (TPCK) also inhibited GDNF‐mediated cells migration and integrin up‐regulation. Stimulation of cells with GDNF induced IκB kinase (IKKα/β) phosphorylation, IκB phosphorylation, p65 Ser^536^ phosphorylation, and κB‐luciferase activity. Furthermore, the GDNF‐mediated increasing of κB‐luciferase activity was inhibited by PD98059, U0126, PDTC and TPCK or MEK, ERK, IKKα, and IKKβ mutants. Taken together, these results suggest that the GDNF acts through MEK/ERK, which in turn activates IKKα/β and NF‐κB, resulting in the activations of αvβ3 integrin and contributing the migration of human chondrosarcoma cells. J. Cell. Physiol. 220: 499–507, 2009. © 2009 Wiley‐Liss, Inc.